Few molecules sit at as many intersections of cell biology as NAD+. It is the electron carrier that keeps glycolysis, the TCA cycle and oxidative phosphorylation running, and it is simultaneously a consumed substrate for two enzyme families that have become central to ageing and metabolic research: the sirtuins and the poly(ADP-ribose) polymerases. Those two roles are studied with different methods and place different demands on the reagent, which is why NAD+ handling deserves more thought than its appearance as a simple white powder suggests.

Role one: the redox coenzyme

As a coenzyme, NAD+ accepts electrons and becomes NADH, and the NAD+/NADH ratio is a direct readout of the redox state of a cell or a preparation. Dehydrogenase assays depend on this chemistry: the reduction of NAD+ to NADH produces a measurable absorbance change at 340 nm, which is the basis of a very large share of the metabolic assays run in research laboratories. For these experiments NAD+ is a consumable reagent used at defined concentration, and what matters most is that the starting concentration is accurate and reproducible.

Role two: the consumed substrate

Sirtuins remove acetyl groups from proteins and PARPs build poly(ADP-ribose) chains during the DNA damage response — and both reactions consume NAD+ by cleaving it. In this role NAD+ is not recycled, it is spent, which is why the literature on ageing and metabolic stress pays so much attention to whether cellular NAD+ availability becomes limiting. Published work describes declining tissue NAD+ levels with age and examines whether restoring availability changes sirtuin activity, mitochondrial function or DNA-repair signalling in cell and animal models. This is the research context in which NAD+ precursors such as nicotinamide riboside and NMN are studied alongside the coenzyme itself.

An important practical consequence: in sirtuin and PARP assays, the NAD+ concentration can become the rate-limiting factor. An error of a few percent in the prepared concentration propagates directly into the measured enzyme activity, which is exactly the kind of systematic error that produces results no one can replicate.

Stability: the issue that ruins assays quietly

NAD+ hydrolyses in aqueous solution, and the rate increases at neutral to alkaline pH and with temperature. A working solution left on the bench for hours is not the same reagent it was when prepared. The practical rules that follow are simple:

• Prepare working solutions fresh, from the bulk powder, on the day of use.
• Keep solutions cold and away from light; avoid leaving them at room temperature between plates.
• Match the buffer to the assay: acidic or mildly buffered conditions slow hydrolysis substantially.
• Run a blank or standard curve from the same freshly prepared stock, so a degradation effect shows up as a shifted standard rather than a mysterious result.

Storage of the bulk material

The powder is hygroscopic, so keep it desiccated at −20 °C, protected from light, and let the vial equilibrate to room temperature before opening — condensation drawn into a cold vial is a common source of moisture damage. Divide large quantities into aliquots if the vial will be opened repeatedly. A 1000 mg vial suits laboratories that prepare their own working stocks at defined molarity across many plates rather than working from small analytical portions.

Because NAD+ is used as a substrate rather than a receptor ligand, verification is straightforward and unambiguous: purity by HPLC, identity by mass confirmation. Documentation for the current batch, and the reference data including CAS number, formula and molecular weight, are listed on our NAD+ 1000 mg product page, with available results published in the lab results database.

NAD+ supplied by Healthy Peps is a laboratory research reagent. It is not intended for human or veterinary consumption and is not intended to diagnose, treat, cure or prevent any disease.